Very positive 2024 results: +40% in turnover
Hygie31 innovates every year by developing its exclusive brands, which are only sold in its network of pharmacies and over-the-counter pharmacy, healthcare & beauty product stores, and now boasts the most extensive catalogue on the market with over 800 references covering 12 pharmacy categories . These products, mainly manufactured in France, particularly in Occitania, and made with natural and/or organic ingredients, regularly win awards. For example, the Natlas haircare range anti-dandruff shampoo won a "Beauty Award" ("Victoire de la Beauté") in 2024.
Our exclusive brand products, with their premium-quality development and attractive prices, are winning over an increasing number of patientss. In 2024, our exclusive brands generated turnover of 14 million euro, i.e. up by 40% vs 2023. En 2024, notre MEX ont ainsi réalisé 14M€ de CA, soit une hausse de 40% vs 2023.
In the Pharmacie Lafayette network, some 6,300 units are sold every day thanks to 5 leading
brands: Minolvie, Aromaya, Stentil, Sephyto and Authentine. And, over the last 18 months, Hygie31
Group enriched its catalogue with 100 new references available to local consortia as well as the
Pharmacie Lafayette and Parapharmacie Lafayette network.
Our exclusive brands, a real
argument upholding our patientss' purchasing power, the appeal of our pharmacies and patients
loyalty, are also an undeniable asset in contributing to our pharmacists' increased profit margins (up
to 60%).
2025, a strategic plan to boost business development and promote sales
In France and Spain, exclusive brands are supported by a powerful business plan for 2025, which aims to exceed 18 million euro in turnover.
In light of this, Hygie31 Group plans to strengthen its positions on its 5 leading brands, which will account for a 5% market share in the pharmacy e-over-the-counter pharmacy, healthcare & beauty product segment.
At the same time, it will continue to launch new ranges such as HAUTHERM, a new skincare-cosmetics brand and will step up the ranges dedicated to local consortia to enhance their catalogue via the HygieStore business driver.
To meet patients expectations, in particular for everyday products, Hygie31 will focus on developing products with strong market potential, as always with controlled prices and in line with the Group's CSR approach.
Pharmacists and their pharmacy teams are also key to this strategy as Hygie31 Group will ramp up product training and communication namely via its Hygie Academy training platform. With these growth perspectives in mind, the Group intends to make its BU dedicated to Exclusive Brands the Group's Number 1 laboratory by 2030, with an announced target of 15% market share.